BioCube, Inc.
BICB
$0.0002
-$0.0022-91.67%
| 07/31/2013 | 04/30/2013 | 01/31/2013 | 10/31/2012 | 07/31/2012 | |
|---|---|---|---|---|---|
| Net Income | -219.39% | -122.90% | -734.61% | 27.01% | 62.63% |
| Total Depreciation and Amortization | 330.34% | 326.98% | 180.60% | 1,592.65% | 3,000.00% |
| Total Amortization of Deferred Charges | 100.00% | 100.00% | -- | -101.65% | -147.74% |
| Total Other Non-Cash Items | 260.61% | -124.41% | 109.26% | -56.75% | -118.24% |
| Change in Net Operating Assets | 59.40% | 55.58% | 31.44% | -1.53% | -17.18% |
| Cash from Operations | 99.31% | -427.59% | -433.91% | -317.61% | -387.84% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -100.00% | 500.00% | 500.00% | 377.94% | 414.71% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -100.00% | 500.00% | 500.00% | 377.94% | 414.71% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 77.27% | 25.00% | 6.67% | 39.13% | -83.33% |
